Biobank collecting blood, tissue and data from skin cancer patients
Collects blood and tissue samples and clinical data from people with skin cancer.
Plain-language title generated from the registry record
Registry title: Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker
Key facts
- Where
- Leuven, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with skin melanoma, adults with non-melanoma skin cancer, and healthy adults. Blood and tissue samples and health information are collected for a biobank.
- Age
- Adults over 18 years of age
- Sex
- All sexes can join
- Disease stage
- Cutaneous melanoma or non-melanoma skin cancer; healthy controls can also join
Main reasons for not taking part
- People who cannot or do not want to give informed consent
Read by machine on 12 November 2026.
Where in Belgium
- UZLeuven, Department of DermatologyLeuven, BelgiumContact: Sofie Van Kelst, BscTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Trial code
- NCT07266142
- Record updated
- 12 June 2026
- Original description
The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma, non-melanoma skin cancer and healthy controls.Read full original descriptionShow less
Prospective Collection of Clinical Data and Human Body Material (HBM): Blood (Serum, Plasma, DNA) and Tissue of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls. Biobank Huidkanker
The goal of this clinical trial is to set up a prospective, fit-for-purpose collection of human body material (HBM)-blood (serum, plasma, DNA) and tissue-and standardized clinical data of patients with cutaneous melanoma, non-melanoma skin cancer and healthy controls.
The main questions it aims to answer are:
* To create a biobank with samples of human body material (HBM): blood (serum/plasma/DNA) and tissue and clinical data of patients with cutaneous melanoma, non-melanoma and helathy controls. * To support future research questions (after specific approval of the Ethics Committee) by using the biobank (through satellite protocols).
If there is a comparison group: Not applicable (umbrella protocol for collection only).
Participants will:
* Share demographics, medical and surgical history, risk factors. * Complete Cancer Worry Scale questionnaire. * Provide biological samples:
* Blood samples (serum, plasma, DNA). * Tissue samples (residual tissue or additional biopsy if consented).
Inclusion: Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures; Adult subjects (>18 years of age) at time of enrolment; Subjects diagnosed with cutaneous melanoma, Non-melanoma skin cancer or healthy controls; Adult subjects able and willing to provide informed consent.
Exclusion: Subjects unable or not willing to provide informed consent; Pregnancy (or willing to become pregnant) is NOT an exclusion criteria (unless specified in the respective satellite protocols.